Skip to Content

66 Y (Lamivudine 150 mg)

Pill imprint 66 Y has been identified as Lamivudine 150 mg.

Lamivudine is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Lamivudine 150 mg 66 Y  Front
Lamivudine 150 mg 66 Y  Back
Lamivudine
Imprint:
66 Y
Strength:
150 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Aurobindo Pharma USA, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

(web3)